Cargando…
Immune response evaluation criteria in solid tumors for assessment of atypical responses after immunotherapy
In 2017, immune response evaluation criteria in solid tumors (iRECIST) were introduced to validate radiologic and clinical interpretations and to better analyze tumor’s response to immunotherapy, considering the different time of following and response, between this new therapy compared to the stand...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173324/ https://www.ncbi.nlm.nih.gov/pubmed/34131564 http://dx.doi.org/10.5306/wjco.v12.i5.323 |